Issue 000 | U.S. Pilot | US

ARTL

ARTELO BIOSCIENCES, INC.

Passing Verified 10-Q | 2026-05-14 Filing currency: USD
Margin of Safety 83.7%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
10,421,000USD
Total Liabilities
5,846,000USD
NCAV
4,575,000USD
Cash
10,273,000USD
NCAV per share
6.80USD/share
Evidence
10 annual | 24 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one ARTL, then regenerate the site.

Known Unknowns

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-08-31
10-K
USD
2020-08-31
10-K
USD
2019-08-31
10-K
USD
2018-08-31
10-K
USD
2017-08-31
10-K
USD
2016-08-31
10-K
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -11,404,000 -10,108,000 -9,930,000 -10,287,000 -7,441,000 -4,685,775 -3,209,531 -2,343,491 -232,789 -29,690
Net Income -12,879,000 -9,826,000 -9,289,000 -10,083,000 -7,437,000 -4,654,862 -2,172,176 -2,343,491 -234,889 -29,690
Cash From Operations -8,520,000 -8,350,000 -8,207,000 -8,008,000 -6,141,000 -4,347,382 -2,792,676 -1,610,020 -216,821 -18,489
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash And Equivalents 600,000 n/a n/a 6,888,000 6,629,000 2,142,072 4,423,965 337,424 572,775 3,590
Accounts Receivable n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 695,000 2,557,000 10,980,000 18,322,000 10,317,000 2,337,199 4,442,588 396,435 574,275 3,590
Total Assets 2,801,000 4,698,000 13,043,000 20,424,000 12,635,000 4,376,862 6,482,726 396,998 574,275 3,590
Total Current Liabilities 4,044,000 1,772,000 1,291,000 998,000 526,000 502,177 1,021,513 531,972 29,438 17,390
Total Liabilities 4,073,000 1,841,000 1,291,000 1,021,000 593,000 501,000 n/a n/a n/a 17,390
Shareholders Equity -1,272,000 2,857,000 11,752,000 19,403,000 12,042,000 3,874,685 5,461,213 -134,974 544,837 -13,800
Shares Outstanding 2,018,746 3,281,032 3,188,959 2,855,688 24,526,703 4,991,587 3,353,616 14,002,293 11,327,302 7,640,000
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 1,029,000 3,223,000 2,960,000 n/a n/a n/a 2,172,465 4,362,293 1,927,302 n/a
Weighted Avg Shares Basic n/a n/a n/a n/a n/a n/a 2,172,465 1,277,527 n/a n/a
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-12-31
10-K
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-11-30
10-Q
USD
2021-08-31
10-K
USD
2021-08-31
10-K
USD
2021-08-31
10-K
USD
2021-05-31
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -2,689,000 -2,786,000 -3,089,000 -3,150,000 -2,379,000 -3,812,000 -1,195,000 -2,512,000 -2,589,000 -3,240,000 -2,614,000 -1,784,000 -2,292,000 -3,476,000 -3,476,000 -3,476,000 -2,394,000 -2,471,000 -1,946,000 -2,552,000 -1,886,867 -1,886,867 -1,886,867 -2,251,412
Net Income -2,958,000 -4,166,000 -3,120,000 -3,221,000 -2,372,000 -3,778,000 -1,132,000 -2,433,000 -2,483,000 -3,073,000 -2,449,000 -1,599,000 -2,168,000 -3,339,000 -3,339,000 -3,339,000 -2,330,000 -2,449,000 -1,965,000 -2,548,000 -1,886,642 -1,886,642 -1,886,642 -2,249,792
Cash From Operations -1,191,000 -2,911,000 -3,498,000 -514,000 -1,597,000 -2,567,000 -778,000 -2,063,000 -2,942,000 -2,596,000 -1,802,000 -1,623,000 -2,186,000 -2,293,000 -2,293,000 -2,293,000 -1,696,000 -1,966,000 -2,053,000 -1,926,000 -1,541,315 -1,541,315 -1,541,315 -1,780,589
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash And Equivalents 10,273,000 600,000 n/a n/a n/a n/a n/a n/a n/a n/a 2,639,000 5,719,000 6,916,000 6,888,000 6,888,000 6,888,000 7,136,000 12,122,000 10,350,000 14,047,000 6,629,000 6,629,000 6,629,000 10,052,288
Total Current Assets 10,421,000 695,000 1,827,000 2,233,000 1,382,000 2,557,000 4,986,000 6,168,000 8,188,000 10,980,000 13,428,000 14,602,000 16,386,000 18,322,000 18,322,000 18,322,000 20,303,000 22,282,000 24,589,000 25,355,000 10,317,000 10,317,000 10,317,000 10,300,283
Total Liabilities 5,846,000 4,073,000 4,900,000 5,763,000 2,863,000 1,841,000 775,000 1,027,000 817,000 1,291,000 921,000 609,000 840,000 1,021,000 1,021,000 1,021,000 512,000 567,000 924,000 718,000 593,000 593,000 593,000 n/a
Shares Outstanding 673,008 2,018,746 1,555,493 704,425 3,281,032 3,281,032 3,227,700 3,227,700 3,227,700 3,188,959 3,162,354 2,855,688 2,855,688 2,855,688 2,855,688 2,855,688 2,855,688 42,593,981 42,301,013 42,301,013 24,526,703 24,526,703 24,526,703 23,149,112
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 739,000 1,029,000 787,000 574,000 3,281,000 3,223,000 3,228,000 538,000 3,197,000 2,960,000 2,949,000 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Basic n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 10,421,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 sec/companyfacts/cik=0001621221/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001621221\companyfacts.json
Total Liabilities 5,846,000USD us-gaap:Liabilities 2026-03-31 1.00 sec/companyfacts/cik=0001621221/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001621221\companyfacts.json
Cash 10,273,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 sec/companyfacts/cik=0001621221/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001621221\companyfacts.json
Shares Outstanding 673,008 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 sec/companyfacts/cik=0001621221/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001621221\companyfacts.json
NCAV 4,575,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 6.80USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 83.7% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
D:\Projects\The Data Vault
CIK
0001621221
Company ID
n/a
Selected Annual Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001621221\companyfacts.json
Selected Quarterly Source
D:\Projects\The Data Vault\data\objects\sec\companyfacts\cik=0001621221\companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
25
Imported At
2026-07-04T23:04:24+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001640334-26-000869
CIK
0001621221
Mary Filing Date
2026-05-14
Filing Currency
USD
Internal Discount
83.7%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-14; mary_accession=0001640334-26-000869; mary_cik=0001621221; gnni_supporting_filing_date=2026-05-14; internal_discount=0.836713; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive